Incremental Hospital Cost and Length-of-Stay Associated With Treating Adverse Events Among Medicare Beneficiaries Undergoing Lumbar Spinal Fusion During Fiscal Year 2013
Authors:
- Steven D. CullerSCSteven D. Culler
- David S. JevsevarDJDavid S. Jevsevar
- Kevin J. McGuireKMKevin J. McGuire
- Michael SchlosserMSMichael Schlosser
- Kimberly K. WrightKWKimberly K. Wright
- April W. SimonASApril W. Simon
- 15 October 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 41 (20) , 1613-1620
Abstract
A retrospective study. To report the incremental hospital resource consumption associated with treating selected adverse events experienced by Medicare beneficiaries undergoing a two- or three-level lumbar spinal fusion. Hospitals are increasingly at financial risk for the incremental resources consumed in treating patients experiencing adverse events because of public and private third-party payers’ efforts to base hospital reimbursement on “pay for performance” measures. However, little is known about average incremental resources consumed in treating patients experiencing adverse events following lumbar spinal fusions. The 2013 fiscal year Medicare Provider Analysis and Review file was used to identify 83,658 Medicare beneficiaries who underwent two- or three vertebrae-level lumbar spinal fusion. International Classification of Diseases-9th—Clinical Modification diagnostic and procedure codes were used to identify the frequencies of nine adverse events. This study estimated both the observed and risk-adjusted incremental hospital resources consumed (cost and length of stay [LOS]) in treating Medicare beneficiaries experiencing each adverse event. Overall, 17.7% of Medicare beneficiaries undergoing lumbar spinal fusion experienced at least one of the study's adverse events. Medicare beneficiaries experiencing any complication consumed significantly more hospital resources (incremental cost of $8911) and had longer LOS (incremental stays of 5.7 days). After adjusting for patient demographics and comorbid conditions, incremental cost of treating adverse events ranged from a high of $32,049 (infection) to a low of $9976 (transfusion). Adverse events frequently occur and add substantially to the hospital resource costs of patients undergoing spinal fusion. Shared decision-making instruments should clearly provide these risk estimates to the patient before surgical consideration. Investment in activities that have been shown to reduce specific adverse events is warranted, and this project may allow health systems to prioritize performance improvement areas. Level of Evidence: 3Keywords
This publication has 17 references indexed in Scilit:
- National in-hospital morbidity and mortality trends after lumbar fusion surgery between 1998 and 2008The Journal of Bone and Joint Surgery. British volume, 2012
- Morbidity and mortality of major adult spinal surgery. A prospective cohort analysis of 942 consecutive patientsThe Spine Journal, 2012
- Perioperative Morbidity and Mortality After Anterior, Posterior, and Anterior/Posterior Spine Fusion SurgerySpine, 2011
- The Increasing Morbidity of Elective Spinal Stenosis SurgeryJAMA, 2010
- Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older AdultsJAMA, 2010
- Does Multilevel Lumbar Stenosis Lead to Poorer Outcomes?Spine, 2010
- Degenerative SpondylolisthesisSpine, 2009
- Health-related quality of life (EQ-5D) before and one year after surgery for lumbar spinal stenosisThe Journal of Bone and Joint Surgery. British volume, 2009
- United States Trends in Lumbar Fusion Surgery for Degenerative ConditionsSpine, 2005
- 2001 Volvo Award Winner in Clinical Studies: Lumbar Fusion Versus Nonsurgical Treatment for Chronic Low Back PainSpine, 2001